MMP-9 Is Differentially Expressed in Primary Human Colorectal Adenocarcinomas and Their Metastases
Open Access
- 1 May 2006
- journal article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Research
- Vol. 4 (5) , 293-302
- https://doi.org/10.1158/1541-7786.mcr-06-0003
Abstract
Matrix metalloproteinase-9 (MMP-9) is up-regulated in macrophages in various human cancer types. In human colon cancer, MMP-9 is expressed in a macrophage subpopulation located at the tumor edge, indicating a specific induction of MMP-9 in macrophages in direct association with cancer invasion. To test whether MMP-9 is also induced in tumor edge macrophages in metastases from colorectal adenocarcinomas, we have compared the expression pattern of MMP-9 in primary colorectal adenocarcinomas (n = 15) with that in liver metastases (n = 15) and local lymph node metastases (n = 7) from the same patients by in situ hybridization and immunohistochemistry. In all the colorectal adenocarcinomas, the expression of MMP-9 mRNA and immunoreactivity in macrophages was located at the invasive front. In contrast, only 3 of the 15 liver metastases had MMP-9 mRNA and immunoreactivity at the periphery, and this expression was confined to small foci of macrophages located either among lymphocytes or in a dense desmoplastic stroma. Expression of MMP-9 mRNA and immunoreactivity was in all liver metastases seen in macrophages located in the lumen of malignant glandular structures and in central necrotic tissue. In all the 7 lymph node metastases, MMP-9 mRNA and immunoreactivity was seen in macrophages located in the stromal tissue surrounding the metastases. We conclude that MMP-9 is not up-regulated in tumor edge macrophages in liver metastases like in their primary tumor and local lymph node metastases, suggesting that disseminating colorectal cancer cells can adopt alternative proteolytic mechanisms for invasion depending on the local microenvironment. (Mol Cancer Res 2006;4(5):293–302)Keywords
This publication has 45 references indexed in Scilit:
- Reduced metastasis of transgenic mammary cancer in urokinase-deficient miceInternational Journal of Cancer, 2004
- Localization of tissue inhibitor of metalloproteinases 1 (TIMP‐1) in human colorectal adenoma and adenocarcinomaInternational Journal of Cancer, 2004
- Leading-Edge Myofibroblasts in Human Colon Cancer Express Plasminogen Activator Inhibitor-1American Journal of Clinical Pathology, 2004
- Pro-MMP-9 is a specific macrophage product and is activated by osteoarthritic chondrocytes via MMP-3 or a MT1-MMP/MMP-13 cascadeExperimental Cell Research, 2004
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002
- Cytokeratins 20 and 7 as biomarkersEuropean Journal Of Cancer, 2002
- Cancer Cell Expression of Urokinase-Type Plasminogen Activator Receptor mRNA in Squamous Cell Carcinomas of the SkinJournal of Investigative Dermatology, 2001
- Stromal Expression of MMP‐9 and Urokinase Receptor Is Inversely Associated with Liver Metastasis and with Infiltrating Growth in Human Colorectal Cancer: A Novel Approach from Immune/Inflammatory AspectJapanese Journal of Cancer Research, 1997
- SERUM LEVELS AND IN SITU EXPRESSION OF TNF-α AND TNF-α BINDING PROTEINS IN INFLAMMATORY LIVER DISEASESCytokine, 1996
- Plasma assay of gelatinase B:Tissue inhibitor of metalloproteinase complexes in cancerCancer, 1995